Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Probiotic Lactobacillus Paracasei Lp-33 for the Management of Rhinitis in People Sensitized to Allergens. A Double Blind Randomized Parallel Placebo Controlled Study. (GA2LEN STUDY) BIONATLANTA Project

NCT01096615 is registered in ClinicalTrials.gov with Merck Medication Familiale as lead sponsor.

NCT NCT01096615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01096615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Probiotic Lactobacillus Paracasei Lp-33 for the Management of Rhinitis in People Sensitized to Allergens. A Double Blind Randomized Parallel Placebo Controlled Study. (GA2LEN STUDY) BIONATLANTA Project
Lead sponsor
Merck Medication Familiale
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
September 30, 2011
Enrollment
500 (actual)
Sites
125

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis